Ewa Harasim-Symbor
Overview
Explore the profile of Ewa Harasim-Symbor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
431
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bielawiec P, Harasim-Symbor E, Golaszewska K, Chabowski A, Hodun K, Sztolsztener K
PLoS One
. 2025 Mar;
20(3):e0315905.
PMID: 40036186
Atrial fibrillation (AF) has become the most common arrhythmia of clinical importance. A well-established and recommended therapeutic option for AF is the balloon-based cryoablation (CBA) method. There are still no...
2.
Konstantynowicz-Nowicka K, Sztolsztener K, Chabowski A, Harasim-Symbor E
J Nutr Biochem
. 2025 Feb;
:109865.
PMID: 39986634
Despite extensive research on insulin resistance, which is associated with type 2 diabetes and obesity, there remains a lack of effective and safe methods to treat it. Thus, we hypothesized...
3.
Pedzinska-Betiuk A, Gergs U, Weresa J, Remiszewski P, Harasim-Symbor E, Malinowska B
Pharmaceuticals (Basel)
. 2024 Oct;
17(10).
PMID: 39459019
Background: Hypoxia is one of the most significant pathogenic factors in cardiovascular diseases. Preclinical studies suggest that nonpsychoactive cannabidiol (CBD) and β-adrenoceptor stimulation might possess cardioprotective potential against ischemia-reperfusion injury....
4.
Harasim-Symbor E, Bielawiec P, Pedzinska-Betiuk A, Weresa J, Malinowska B, Konstantynowicz-Nowicka K, et al.
Nutr Metab Cardiovasc Dis
. 2024 Oct;
34(12):2817-2833.
PMID: 39358107
Background And Aims: Hypertension is a potent risk factor for cardiovascular diseases, which are the leading worldwide cause of death. Within time increased blood pressure (BP) induces cardiac contractile dysfunction,...
5.
MacLeod B, Wang C, Brown L, Borkowski E, Nakamura M, Wells K, et al.
J Lipid Res
. 2024 Sep;
65(10):100642.
PMID: 39303984
The production of the omega-3 long-chain polyunsaturated fatty acids (n-3 LCPUFA) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) from alpha-linolenic acid (ALA) relies on the delta-6 desaturase (D6D) enzyme encoded...
6.
Sztolsztener K, Harasim-Symbor E, Chabowski A, Konstantynowicz-Nowicka K
Biomed Pharmacother
. 2024 Aug;
178:117286.
PMID: 39128189
Fat and sugar overconsumption is the cause of increasing worldwide incidence of gastrointestinal tract in inflammatory conditions. The intestinal pre-inflammatory alterations are partially reversible, simultaneously inhibiting the predisposition to colitis....
7.
Bielawiec P, Dziemitko S, Konstantynowicz-Nowicka K, Sztolsztener K, Chabowski A, Harasim-Symbor E
Front Mol Biosci
. 2024 Jun;
11:1401558.
PMID: 38919749
Numerous strategies have been proposed to minimize obesity-associated health effects, among which phytocannabinoids appear to be effective and safe compounds. In particular, cannabigerol (CBG) emerges as a potent modulator of...
8.
Opechowska A, Karpiuk K, Zahorodnii A, Harasim-Symbor E, Chabowski A, Konstantynowicz-Nowicka K
Toxicol Appl Pharmacol
. 2024 Feb;
484:116856.
PMID: 38336253
High-fat diet (HFD) contributes to neuroinflammation forming, hence it is crucial to find safe and effective substances that are able to counteract its progress. The anti-inflammatory properties of phytocannabinoids acquired...
9.
Bzdega W, Kurzyna P, Harasim-Symbor E, Holownia A, Chabowski A, Konstantynowicz-Nowicka K
Nutrients
. 2023 Oct;
15(20).
PMID: 37892425
Background: Cannabigerol (CBG), a non-psychotropic phytocannabinoid found in plants, has been the focus of recent studies due to its potential therapeutic properties. We proposed that by focusing on sphingolipid metabolism,...
10.
Sztolsztener K, Bzdega W, Konstantynowicz-Nowicka K, Chabowski A, Harasim-Symbor E
Prostaglandins Other Lipid Mediat
. 2023 Aug;
169:106767.
PMID: 37541613
The study explored the potential protective influence of cannabidiol (CBD) on myocardial inflammation state, with a special focus on arachidonic acid (AA), and oxidative balance in lipid overload conditions. The...